Search Within

Sam Yoon

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Biostatistics Service (6)
  2. Body Imaging Service (6)
  3. Department of Medicine (6)
  4. Department of Pathology and Laboratory Medicine (6)
  5. Epidemiology and Biostatistics (6)
  6. GSK Faculty (6)

More Groups

People
  1. Aimee Crago (6)
  2. Ciara Kelly (6)
  3. Cristina Antonescu (6)
  4. Li-Xuan Qin (6)
  5. Mark Dickson (6)
  6. Mary Keohan (6)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2020 (2)
  4. 2019 (1)
  5. 2018 (1)
Publications
  1. Journal of Clinical Oncology (4)
  2. Clinical Cancer Research (1)
  3. JAMA Oncology (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (1)
  3. American Medical Association (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Phase II trial of imatinib plus binimetinib in patients with treatment-naive advanced gastrointestinal stromal tumor
    Journal Article

    Chi, P.; Qin, L. X.; Nguyen, B.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B.; Crago, A. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Kelly, C. M.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Qin, L. X.; Adamson, T.; Condy, M. M.; Biniakewitz, M.; Phelan, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save